Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NFL101 for Tobacco Cessation (CESTO)
NCT02521701Phase 1Completed
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Dec 2014
- Primary completion
- Dec 2015
- Modality
- Botanical drug
- Countries
- 1
01
Overview
Phase 1, open-label trial of nfl-101 in Tobacco Use Disorder (TUD) (2 arms), sponsored by Institut du Cancer de Montpellier. Primary endpoint: Number of Participants with Adverse Events at 1 year. Started Dec 2014; status: completed.
02
Drugs
nfl-101
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02521701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02521701.